Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Concannon

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Breast Cancer Research and Treatment|December 17, 2010
Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier statusJane C Figueiredo, Jennifer D Brooks, David V Conti, et al.
Breast (Edinburgh, Scotland)|September 14, 2020
A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE studyJennifer D Brooks, John D Boice, Roy E Shore, et al.
Breast Cancer Research : BCR|July 21, 2017
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study populationAnne S Reiner, Charles F Lynch, Julia S Sisti, et al.
Breast Cancer Research and Treatment|February 6, 2010
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancerKerryn W Reding, Jonine L Bernstein, Bryan M Langholz, et al.
Nature Genetics|May 12, 2009
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetesJeffrey C Barrett, David G Clayton, Patrick Concannon, et al.
Breast Cancer Research : BCR|November 18, 2011
Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) StudySharon N Teraoka, Jonine L Bernstein, Anne S Reiner, et al.
Diabetes|August 15, 2012
Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetesJoanna M M Howson, Jason D Cooper, Deborah J Smyth, et al.
Science (New York, N.Y.)|February 1, 2013
Gut microbiomes of Malawian twin pairs discordant for kwashiorkorMichelle I Smith, Tanya Yatsunenko, Mark J Manary, et al.
Human Mutation|January 28, 2010
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE studyAke Borg, Robert W Haile, Kathleen E Malone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2Kathleen E Malone, Colin B Begg, Robert W Haile, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Breast Cancer Research and Treatment|December 17, 2010
Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier statusJane C Figueiredo, Jennifer D Brooks, David V Conti, et al.
Breast (Edinburgh, Scotland)|September 14, 2020
A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE studyJennifer D Brooks, John D Boice, Roy E Shore, et al.
Breast Cancer Research : BCR|July 21, 2017
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study populationAnne S Reiner, Charles F Lynch, Julia S Sisti, et al.
Breast Cancer Research and Treatment|February 6, 2010
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancerKerryn W Reding, Jonine L Bernstein, Bryan M Langholz, et al.
Nature Genetics|May 12, 2009
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetesJeffrey C Barrett, David G Clayton, Patrick Concannon, et al.
Breast Cancer Research : BCR|November 18, 2011
Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) StudySharon N Teraoka, Jonine L Bernstein, Anne S Reiner, et al.
Diabetes|August 15, 2012
Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetesJoanna M M Howson, Jason D Cooper, Deborah J Smyth, et al.
Science (New York, N.Y.)|February 1, 2013
Gut microbiomes of Malawian twin pairs discordant for kwashiorkorMichelle I Smith, Tanya Yatsunenko, Mark J Manary, et al.
Human Mutation|January 28, 2010
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE studyAke Borg, Robert W Haile, Kathleen E Malone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2Kathleen E Malone, Colin B Begg, Robert W Haile, et al.
Pageof 13